HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Levy Kopelovich Selected Research

2-chloro-5-nitrobenzanilide

1/2013PPARĪ³ antagonist GW9662 induces functional estrogen receptor in mouse mammary organ culture: potential translational significance.
4/2012Effects of bacterial and presystemic nitroreductase metabolism of 2-chloro-5-nitro-N-phenylbenzamide on its mutagenicity and bioavailability.
3/2012Drug-targeted inhibition of peroxisome proliferator-activated receptor-gamma enhances the chemopreventive effect of anti-estrogen therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Levy Kopelovich Research Topics

Disease

96Neoplasms (Cancer)
10/2019 - 03/2002
39Carcinogenesis
06/2019 - 03/2002
21Colonic Neoplasms (Colon Cancer)
02/2015 - 03/2003
20Inflammation (Inflammations)
01/2022 - 11/2003
13Breast Neoplasms (Breast Cancer)
08/2017 - 01/2007
12Colorectal Neoplasms (Colorectal Cancer)
06/2019 - 03/2002
11Carcinoma (Carcinomatosis)
07/2016 - 03/2003
10Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2017 - 03/2004
9Skin Neoplasms (Skin Cancer)
02/2014 - 07/2002
8Adenoma (Adenomas)
01/2016 - 03/2003
8Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
03/2011 - 03/2002
7Obesity
01/2022 - 03/2011
7Basal Cell Carcinoma (Rodent Ulcer)
01/2017 - 03/2004
6Adenocarcinoma
01/2016 - 09/2005
5Prostatic Neoplasms (Prostate Cancer)
01/2013 - 09/2003
4Transitional Cell Carcinoma
01/2016 - 08/2013
4Urinary Bladder Neoplasms (Bladder Cancer)
07/2014 - 03/2005
4Body Weight (Weight, Body)
01/2013 - 04/2006
3Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
01/2021 - 11/2007
3Residual Neoplasm
01/2017 - 01/2013
3Melanoma (Melanoma, Malignant)
12/2015 - 10/2005
3Neoplasm Metastasis (Metastasis)
12/2015 - 05/2009
3Papilloma (Papillomatosis)
01/2011 - 07/2002
3Aberrant Crypt Foci
09/2010 - 10/2009
2Tuberous Sclerosis (Bourneville's Disease)
03/2017 - 12/2004
2Adenocarcinoma of Lung
12/2015 - 09/2013
2Lung Neoplasms (Lung Cancer)
12/2015 - 09/2013
2Li-Fraumeni Syndrome
06/2014 - 03/2014
2Rhabdomyosarcoma
06/2013 - 08/2010

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
06/2019 - 03/2004
14Biomarkers (Surrogate Marker)IBA
10/2019 - 09/2008
13CP 31398IBA
07/2016 - 12/2007
12Pharmaceutical PreparationsIBA
12/2015 - 12/2003
11Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
02/2015 - 03/2003
9DNA (Deoxyribonucleic Acid)IBA
08/2013 - 12/2003
8Sulindac (Copal)FDA LinkGeneric
02/2015 - 03/2003
8Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2015 - 11/2003
8CarcinogensIBA
09/2013 - 01/2005
7Aromatase (CYP19)IBA
01/2022 - 03/2011
7EnzymesIBA
02/2015 - 07/2002
7AzoxymethaneIBA
02/2015 - 04/2006
7Hormones (Hormone)IBA
09/2013 - 11/2006
7Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2008 - 07/2002
6Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2016 - 06/2006
6Celecoxib (Celebrex)FDA Link
02/2015 - 04/2006
6Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
02/2015 - 11/2003
6Transcription Factors (Transcription Factor)IBA
06/2014 - 06/2009
6Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2013 - 11/2003
5Sirolimus (Rapamycin)FDA Link
02/2019 - 07/2011
5Estrogen ReceptorsIBA
08/2017 - 01/2007
5Estrogens (Estrogen)FDA Link
08/2017 - 01/2009
5nitroxy-butyl-acetylsalicylic acidIBA
06/2011 - 11/2003
4PolyaminesIBA
01/2016 - 03/2004
4Cyclin D1IBA
01/2016 - 09/2002
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2014 - 06/2009
4Eflornithine (Ornidyl)FDA Link
09/2013 - 11/2003
4GW 501516IBA
07/2013 - 05/2005
4Progesterone Receptors (Progesterone Receptor)IBA
07/2013 - 04/2012
4Caspase 3 (Caspase-3)IBA
01/2013 - 12/2007
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2013 - 04/2006
4ProteomeIBA
03/2011 - 06/2007
4ResveratrolIBA
01/2011 - 07/2006
4PPAR gammaIBA
01/2009 - 03/2002
4TeaIBA
01/2009 - 07/2002
3Naproxen (Naprosyn)FDA LinkGeneric
01/2021 - 11/2009
3Cadherins (E-Cadherin)IBA
01/2017 - 07/2011
32,2- bis(hydroxymethyl)- 1- azabicyclo(2,2,2,)octan- 3- oneIBA
07/2016 - 10/2010
3MicroRNAs (MicroRNA)IBA
12/2015 - 01/2013
3ProstaglandinsIBA
02/2015 - 11/2003
3LigandsIBA
06/2014 - 09/2005
3CateninsIBA
02/2014 - 01/2010
3Folic Acid (Vitamin M)FDA LinkGeneric
09/2013 - 02/2011
3Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA
09/2013 - 03/2004
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
07/2013 - 03/2002
3Atorvastatin (Lipitor)FDA Link
01/2013 - 04/2006
32-chloro-5-nitrobenzanilideIBA
01/2013 - 03/2012
3CyclinsIBA
09/2012 - 03/2008
3styrylquinazolineIBA
07/2012 - 12/2007
3anthraceneIBA
05/2012 - 01/2009
3Progestins (Progestagens)IBA
05/2012 - 05/2005
3Messenger RNA (mRNA)IBA
10/2010 - 10/2005
3NF-kappa B (NF-kB)IBA
06/2009 - 11/2003
3Phosphotransferases (Kinase)IBA
06/2009 - 10/2006
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
09/2008 - 12/2007
3Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
03/2008 - 07/2002
3ErbB Receptors (EGF Receptor)IBA
07/2007 - 04/2005
2Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
08/2017 - 01/2009
2trans-sodium crocetinate (crocetin)IBA
03/2017 - 12/2004
2VimentinIBA
01/2017 - 07/2011
2licofeloneIBA
01/2016 - 07/2014
24- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA
12/2015 - 09/2013
2TOR Serine-Threonine KinasesIBA
12/2015 - 07/2007
2Anti-Inflammatory Agents (Anti-Inflammatories)IBA
07/2014 - 03/2004
2Biological ProductsIBA
01/2014 - 04/2012
2Fatty Acids (Saturated Fatty Acids)IBA
09/2013 - 03/2011
2MethyltransferasesIBA
08/2013 - 02/2011
2Glucose (Dextrose)FDA LinkGeneric
07/2013 - 01/2010

Therapy/Procedure

24Chemoprevention
01/2021 - 11/2003
7Therapeutics
08/2017 - 05/2005
2Caloric Restriction
01/2022 - 04/2013